Moatly / Stocks / LLY

Eli Lilly and Company (LLY) — what is it worth?

$1,432.29 · $1.3T market cap · Drug Manufacturers - General
Scored from reported financial statements. Data as of 2026-11-11.
Moat
100
Durability of advantage
Management
83
Returns and capital use
Margin of safety
32
Price against value
Buy price
$462.15
Consensus of three methods
Intrinsic value
$924.30
What the business is worth
Margin of safety price
$462.15
Intrinsic value less 50%
10-CAP price
$256.95
Ten times owner earnings
Payback time price
$405.62
Eight years of free cash flow
Moatly AI Insight

Eli Lilly and Company is scored 100 for moat and 83 for management. The management score rests on a return on invested capital of 30.2% and a gross margin of 83.0% — figures that describe a business turning capital into profit efficiently. Debt sits at 1.60x equity.

The valuation runs on assumptions chosen to understate rather than flatter. Growth is modelled at 15.0% a year, below the 22.0% actually measured over the last decade — the model caps growth rather than extrapolating a good run forwards. The exit multiple assumed is 30.0x. That produces an intrinsic value of $924.30, a 10-CAP price of $256.95 and a payback time price of $405.62, with the value zone set at the highest of the three, $462.15. Today's price of $1,432.29 is 210% above it.

A wonderful business at the wrong price is still the wrong price. Eli Lilly and Company scores well on the business and poorly on the entry point, which is the most common shape in a long bull market.

Key figures

Price$1,432.29
Market cap$1.3T
P/E ratio46.5x
Return on invested capital30.2%
Gross margin83.0%
Debt to equity1.60x
Free cash flow yield0.9%
Growth rate used15.0%
Growth rate measured22.0%
Exit multiple assumed30.0x

How it compares

CompanyMoatBuy price
Johnson & Johnson (JNJ)53$90.91
AbbVie Inc. (ABBV)22$113.65
Roche Holding AG (RHHBY)21$60.56
Merck & Co. Inc. (MRK)56$78.55

Be in the know

Subscribe to our Substack for deeper insights on value plays.

Subscribe free

Run your own assumptions

Every number above is built on assumptions that can be changed. In Moatly you can move the growth rate, the exit multiple and the margin of safety and watch every figure recalculate, so you are testing your own view of Eli Lilly and Company rather than accepting ours.

Download on the App StoreGet it on Google Play

Not investment advice. Estimates only, built on stated assumptions that could be wrong. Figures are drawn from reported financial statements and were current as of the date shown. Do your own research.